[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 3,950.00 3,850.00 4,050.00 3,950.00 3,950.00 3,950.00 194 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10.3 8.2 139.4 28.3 206

Bioventix Share Discussion Threads

Showing 1201 to 1222 of 1350 messages
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
DateSubjectAuthorDiscuss
11/5/2020
07:29
Fair enough.
2toptrader
10/5/2020
22:14
2toptrader, the company said as much in the interims. I'm sure there will be a short term drop in testing activity but things will get back to normal and I'm not interested in trying to be to clever with my trading so I'll just hold on.
stepone68
10/5/2020
11:45
I'm guessing that most here are more investors than traders.
trident5
10/5/2020
09:51
I'm not a deramper and I appreciate BVXP is a top co, but the point I'm trying to make is that routine testing will be negatively impacted by Covid-19. This is not "pandemic proof" at all. Try and get a hospital app in this current climate, almost impossible unless an emergency. And by the time we'll get back to normal, there will be such a backlog of more urgent appointments that most of the CY 2020 will be affected. More updates on my twitter handle if interested: htTps://twitter.com/TheAlch95880124/status/1257780283971121156
2toptrader
09/5/2020
13:52
Countries with high Covid mortality rates will have high lockdown rates and as a result higher vitamin D deficiency rates. Has that been disentangled?
trident5
06/5/2020
08:19
Post on Bioventix by Maynard Paton: hTTps://maynardpaton.com/2020/05/01/bioventix-34x-p-e-understandably-reflects-pandemic-proof-outlook-as-h1-dividend-lifted-20-and-margins-hit-80/
robinnicolson
04/5/2020
15:08
Evidence comes from all cases from the start of the pandemic so probably not associated with the lock down. Anyway, more VitD testing is likely.
tadders2
04/5/2020
14:57
But isn't that just reflecting that we're all getting less sunshine with lockdown?
trident5
04/5/2020
14:28
Now evidence that patients with low Vit D assays are more likely to be severely affected with COVID 19.
tadders2
28/4/2020
15:14
This is surprisingly strong. Re-investment of dividends?
trident5
26/4/2020
20:42
Lot more people with vitamin D deficiency in this lockdown, surely.
trident5
26/4/2020
20:29
Do you mean year to June 2020 will be the peak? i.e. higher than 2019 results, but will be down in 2021?
stepone68
23/4/2020
11:53
Hydrus, I agree with you. Long term this is a strong hold, but short-mid term I would argue it's a sell.I did what the ceo did.
2toptrader
21/4/2020
16:53
Interesting chippy thanks. Long term hold for me regardless (and has been for many years).
hydrus
21/4/2020
16:29
Hydrus, Many of those admitted to hospital with covid 19 will have their troponin levels checked, as the actions of the virus can damage the heart.
chippyfriday
16/4/2020
11:20
'Within the field of our customers in downstream in vitro diagnostics, it is possible that some routine diagnostic testing could be reduced as hospitals refocus towards virus-infected patients and this could have an impact on Bioventix into the future. '
hydrus
16/4/2020
11:19
Impact on BVXP potentially in short term, which they alluded to in the results: https://www.theguardian.com/world/2020/apr/16/coronavirus-concern-heart-attack-stroke-patients-delay-seeking-help
hydrus
03/4/2020
07:03
Don't forget the new shares weren't freebies. He had to raise the cash to pay for them and the benefit of the discount to the market price would be subject to income tax at his highest rate, payable at the time as paye.
melton john
03/4/2020
04:03
In relation to his holding not that big! Please note: Following the Sale and the Exercise, Peter Harrison's total beneficial interest in the Company will be 416,676 Ordinary Shares representing approximately 8.0% of the Company. Wish I had as many!
lauders
02/4/2020
14:54
Big director dump
dan_the_epic
31/3/2020
14:44
Hi ScillyFool, Agreed, a very positive report and maintaining the dividend, whilst so many firms are cancelling or deferring, is a huge sign of confidence. The Troponin growth was the highlight amongst the other other good news, whilst a tab behind management's expectations, it bodes very well for the future. Regards, Maddox
maddox
30/3/2020
21:44
Nice to see the Board are going to continue with the progressive dividend policy. A 20% increase in the interim dividend added to the usual increased final and the increased special dividend make this a no-brainer AIM share. Even the share price is heading back up towards the £40 mark. Wish I'd bought more last week!
scillyfool
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
ADVFN Advertorial
Your Recent History
LSE
BVXP
Bioventix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210919 05:40:14